Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Not Yet Recruiting NCT07914972

Treatment Pattern and Patient Outcomes Among Stage I-II Unresected NSCLC Patients

Conditions: Non-small Cell Lung Cancer, NSCLC, Stage I-II Unresected NSCLC

Sex: All

Ages: 18 Years – N/A

Healthy volunteers: No

Enrollment: 440

Sponsor: AstraZeneca

Summary

The iTERESA study is a retrospective, cross-sectional, non interventional, multi-country observational HCPs survey designed to characterize real-world management of adult patients with stage I-II unresected NSCLC.

Eligibility Criteria

Inclusion Criteria: * \- Patient with unresected stage I-II NSCLC * \- Patient aged 18 years or older at the time of diagnosis Exclusion Criteria: * \- Patients with anaplastic lymphoma kinase mutation (ALK) * \- Patients with previous history of cancer * \- Patients without post-diagnosis information

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07914972). StuddyBuddy aggregates publicly available trial information.